Commentary | Published:

HIV-AIDS: much accomplished, much to do

Nature Immunology volume 14, pages 11041107 (2013) | Download Citation

Subjects

Abstract

As a result of decades of research-driven breakthroughs in basic and clinical science and recent advances in the broad-scale implementation of interventions for the prevention and treatment of infection with HIV, a turning point has been reached in the global HIV-AIDS pandemic. To end the pandemic and achieve the goal of an AIDS-free generation, researchers and clinicians must follow the dual pathway of optimizing the implementation of existing prevention and treatment interventions and discovering with basic and clinical research new and effective tools in both of these arenas.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013, (2013).

  2. 2.

    et al. Curr. Opin. Infect. Dis. 26, 17–25 (2013).

  3. 3.

    World Health Organization, UNICEF, UNAIDS. Global update on HIV treatment 2013: Results, impact and opportunities, (2013).

  4. 4.

    et al. Clin. Infect. Dis. 52, 793–800 (2011).

  5. 5.

    HIV Prevention Trials Network. .

  6. 6.

    HIV Prevention Trials Network. .

  7. 7.

    et al. N. Engl. J. Med. 365, 493–505 (2011).

  8. 8.

    et al. Science 339, 966–971 (2013).

  9. 9.

    Centers for Disease Control and Prevention. HIV Surveillance Supplemental Report, (2012).

  10. 10.

    et al. AIDS 26, 893–896 (2012).

  11. 11.

    et al. MMWR Morb. Mortal. Wkly. Rep. 61, 971–976 (2012).

  12. 12.

    et al. Ann. Intern. Med. 159, 51–60 (2013).

  13. 13.

    , & Cochrane Libr. 7, CD007189 (2012).

  14. 14.

    & Curr. HIV/AIDS Rep. 10, 142–151 (2013).

  15. 15.

    et al. Clin. Infect. Dis. 548, 806–815 (2009).

  16. 16.

    et al. AIDS 26, 609–615 (2012).

  17. 17.

    . HIV drop follows increase in circumcision. medpage today, (7 March 2012).

  18. 18.

    & N. Engl. J. Med. 365, 873–875 (2011).

  19. 19.

    et al. N. Engl. J. Med. 361, 2209–2220 (2009).

  20. 20.

    et al. N. Engl. J. Med. 366, 1275–1286 (2012).

  21. 21.

    & Immunity 37, 412–425 (2012).

  22. 22.

    et al. Nat. Rev. Immunol. 12, 607–614 (2012).

  23. 23.

    & Proc. Natl. Acad. Sci. USA 96, 10958–10961 (1999).

  24. 24.

    et al. Proc. Natl. Acad. Sci. USA 96, 15109–15114 (1999).

  25. 25.

    Science 339, 1134 (2013).

  26. 26.

    et al. PLoS Pathog. 9, e1003211 (2013).

  27. 27.

    Centers for Disease Control and Prevention. Today's HIV/AIDS epidemic, (2013).

Download references

Author information

Affiliations

  1. Anthony S. Fauci, Gregory K. Folkers and Carl W. Dieffenbach are with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

    • Anthony S Fauci
    • , Gregory K Folkers
    •  & Carl W Dieffenbach

Authors

  1. Search for Anthony S Fauci in:

  2. Search for Gregory K Folkers in:

  3. Search for Carl W Dieffenbach in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Anthony S Fauci.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ni.2735

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing